Fordyce Angiokeratoma: Definition and Treatment
Fordyce angiokeratoma (angiokeratoma of Fordyce) consists of benign vascular lesions presenting as dark red to blue-black papules with a scaly surface, most commonly located on the scrotum in males and labia majora in females, and when symptomatic or cosmetically concerning, pulsed dye laser (PDL) or long-pulsed Nd:YAG laser are the preferred treatment options. 1, 2, 3
Clinical Presentation and Pathophysiology
Fordyce angiokeratomas are benign vascular tumors characterized by:
- Small, slightly raised, purplish-red to blue-black, non-blanching papules that range from pinhead size to several millimeters 4
- Progressive increase in number and size with age, typically becoming more prominent over time 4
- Common locations: scrotum, penis, labia majora, and pubic area 1, 3, 5
- Pathophysiology: caused by weakening of capillary walls and vascular ectasia (dilation) within the epidermis and dermis 4
- Histology: marked dilation of papillary dermal vessels forming large, blood-filled cavernous channels 5
Clinical Significance
- Usually asymptomatic but may cause patient anxiety and social embarrassment 1, 3
- Bleeding risk: lesions may bleed spontaneously or after mechanical trauma, including sexual intercourse 1, 3
- Large genital lesions are particularly susceptible to thrombosis and bleeding 4
- Incidence increases with age, affecting approximately half of older males 6
Important Differential Diagnosis
Must differentiate from malignant melanoma, angiosarcoma, and other pigmented lesions, particularly when lesions are dark or irregular 3
Treatment Approach
When to Treat
Treatment is indicated for:
- Symptomatic lesions (bleeding, itching, pain) 6
- Cosmetic concerns causing patient distress 1, 3, 6
- Recurrent bleeding after trauma 1, 3
Asymptomatic lesions do not require treatment as they are benign 1
First-Line Treatment: Laser Therapy
Pulsed Dye Laser (PDL)
PDL at 585-595 nm is the preferred first-line treatment for Fordyce angiokeratoma, offering excellent efficacy with minimal side effects:
- Parameters: 5.5-8.0 J/cm² fluence, variable pulse width, with Dynamic Cooling Device (DCD) 1, 3
- Treatment sessions: 1-7 sessions (mean 3.38 sessions), with intervals of 1-3 months 3
- Efficacy:
- Side effects: transient purpura and pain in all patients, bleeding during treatment in 42% of cases, but no permanent complications, scarring, or dyspigmentation 1, 3
- Recurrence: observed in 17% of patients after 0.5-1 year 3
Long-Pulsed Nd:YAG Laser
Long-pulsed Nd:YAG laser (1064 nm) is an excellent alternative, particularly for darker skin types:
- Parameters: 90-130 J/cm² energy, 10-20 ms pulse duration, 5-7 mm spot size 2
- Clinical endpoint: lesions should shrink and turn pale immediately after irradiation 2
- Treatment interval: minimum 8 weeks between sessions 2
- Efficacy: 82% cured, 18% improved, with mean 2.2 treatment sessions 2
- Advantages: simple, rapid, no bleeding during treatment, no scar formation 2
- Patient satisfaction: 100% in reported series 2
Alternative Treatment Options
When laser therapy is unavailable or contraindicated:
Cryotherapy
- Widely used method with good efficacy 6
- Advantages: readily available, lower cost 6
- Disadvantages: may cause more discomfort during healing, potential for scarring 6
Electrocauterization
- Effective for symptomatic lesions 6
- Considerations: may cause more pain and longer recovery compared to laser 6
- Risk of bleeding and wound infection during procedure 6
Radiofrequency Ablation
Surgical Excision
- Reserved for large, pedunculated lesions or when histological confirmation is needed 4
- More invasive with higher risk of scarring 6
Treatment Algorithm
- Confirm diagnosis clinically (dark red to blue-black papules on genital skin with scaly surface) 1, 3, 5
- If diagnostic uncertainty exists (concern for melanoma or angiosarcoma), obtain biopsy before treatment 3, 5
- For isolated or few lesions:
- For multiple extensive lesions:
- If laser unavailable: cryotherapy or electrocauterization 6
- Follow-up at 6-12 months to monitor for recurrence 3
Critical Pitfalls to Avoid
- Do not confuse with Fabry disease angiokeratomas, which are systemic manifestations of α-galactosidase A deficiency, appear earlier (age 5-13), and require enzyme replacement therapy rather than local treatment 4
- Fabry disease angiokeratomas typically involve hips, back, thighs, buttocks, and oral mucosa, and are associated with acroparesthesias, cornea verticillata, and renal/cardiac disease 4
- Always rule out malignancy when lesions are atypical, rapidly growing, or irregularly pigmented 3
- Avoid aggressive ablative treatments that may cause genital scarring and decreased patient satisfaction 6
- Counsel patients about recurrence risk (up to 17%) and need for potential retreatment 3
- Warn about transient purpura lasting several days after PDL treatment to manage expectations 1, 3